NCT04814537View on ClinicalTrials.gov

Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

March 23, 2022

Study Completion Date

March 23, 2022

Conditions
Labor PainAnalgesia
Interventions
DRUG

Bupivacaine Hydrochloride

Local Anesthetic Agent

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04814537 - Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques | Biotech Hunter | Biotech Hunter